Pittenger & Anderson Inc. grew its stake in shares of Walgreens Boots Alliance Inc (NASDAQ:WBA) by 82.9% during the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 27,280 shares of the pharmacy operator’s stock after purchasing an additional 12,365 shares during the period. Pittenger & Anderson Inc.’s holdings in Walgreens Boots Alliance were worth $1,989,000 as of its most recent filing with the Securities and Exchange Commission.
Other hedge funds and other institutional investors also recently made changes to their positions in the company. BlueMountain Capital Management LLC bought a new stake in shares of Walgreens Boots Alliance during the second quarter worth about $103,000. CSat Investment Advisory L.P. bought a new stake in shares of Walgreens Boots Alliance during the second quarter worth about $104,000. Squar Milner Financial Services LLC bought a new stake in shares of Walgreens Boots Alliance during the second quarter worth about $106,000. Kaizen Advisory LLC increased its position in shares of Walgreens Boots Alliance by 128.6% during the second quarter. Kaizen Advisory LLC now owns 1,925 shares of the pharmacy operator’s stock worth $116,000 after acquiring an additional 1,083 shares in the last quarter. Finally, Camarda Financial Advisors LLC bought a new stake in shares of Walgreens Boots Alliance during the second quarter worth about $137,000. Hedge funds and other institutional investors own 61.92% of the company’s stock.
In related news, COO Ornella Barra bought 1,700,000 shares of Walgreens Boots Alliance stock in a transaction dated Monday, July 16th. The stock was purchased at an average cost of $65.15 per share, with a total value of $110,755,000.00. The acquisition was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, Director William C. Foote sold 2,736 shares of the stock in a transaction that occurred on Thursday, August 2nd. The shares were sold at an average price of $65.99, for a total transaction of $180,548.64. Following the transaction, the director now directly owns 10,943 shares of the company’s stock, valued at $722,128.57. The disclosure for this sale can be found here. 14.80% of the stock is owned by corporate insiders.
Several research firms have recently commented on WBA. ValuEngine raised shares of Walgreens Boots Alliance from a “sell” rating to a “hold” rating in a research report on Friday. SunTrust Banks boosted their target price on shares of Walgreens Boots Alliance to $75.00 and gave the stock a “hold” rating in a research report on Friday. Loop Capital boosted their target price on shares of Walgreens Boots Alliance from $80.00 to $82.00 and gave the stock a “buy” rating in a research report on Friday. JPMorgan Chase & Co. upped their price objective on shares of Walgreens Boots Alliance from $83.00 to $91.00 and gave the stock an “overweight” rating in a research report on Monday, October 8th. Finally, Royal Bank of Canada set a $82.00 price objective on shares of Walgreens Boots Alliance and gave the stock an “outperform” rating in a research report on Monday, October 8th. One analyst has rated the stock with a sell rating, eleven have assigned a hold rating, seven have issued a buy rating and two have given a strong buy rating to the stock. The stock presently has an average rating of “Hold” and a consensus target price of $76.94.
Shares of WBA stock opened at $73.50 on Friday. Walgreens Boots Alliance Inc has a 52-week low of $59.07 and a 52-week high of $80.68. The company has a quick ratio of 0.47, a current ratio of 0.93 and a debt-to-equity ratio of 0.44. The stock has a market capitalization of $72.35 billion, a price-to-earnings ratio of 14.41, a PEG ratio of 1.11 and a beta of 1.04.
Walgreens Boots Alliance (NASDAQ:WBA) last issued its quarterly earnings data on Thursday, October 11th. The pharmacy operator reported $1.48 earnings per share (EPS) for the quarter, topping the Zacks’ consensus estimate of $1.45 by $0.03. Walgreens Boots Alliance had a net margin of 3.36% and a return on equity of 21.22%. The business had revenue of $33.44 billion during the quarter, compared to the consensus estimate of $33.64 billion. On average, equities analysts expect that Walgreens Boots Alliance Inc will post 5.98 EPS for the current year.
Walgreens Boots Alliance Company Profile
Walgreens Boots Alliance, Inc operates as a pharmacy-led health and wellbeing company. It operates through three segments: Retail Pharmacy USA, Retail Pharmacy International, and Pharmaceutical Wholesale. The Retail Pharmacy USA segment sells prescription drugs and an assortment of general merchandise, including non-prescription drugs, beauty products, photo finishing, seasonal merchandise, greeting cards, and convenience foods through its retail drugstores and convenient care clinics.
Featured Story: Marijuana Stocks Future Looks Bright
Want to see what other hedge funds are holding WBA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Walgreens Boots Alliance Inc (NASDAQ:WBA).
Receive News & Ratings for Walgreens Boots Alliance Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Walgreens Boots Alliance and related companies with MarketBeat.com's FREE daily email newsletter.